Catalyst
Slingshot members are tracking this event:
CTI BioPharma Initiates Rolling Submission of U.S. New Drug Application for Pacritinib for the Treatment of Patients with Myelofibrosis, Completion date overdue
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 09, 2016
Occurred Source:
http://investors.ctibiopharma.com/phoenix.zhtml?c=92775&p=irol-newsArticle&ID=2137027
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Nda, Pacritinib, Myelofibrosis
